# PT-141 bremelanotide phase 2b: responder rates in women

Source: https://pepvault.app/research/pt-141-althof-2019

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [PT-141](https://pepvault.app/research#pt-141)

Randomized trial · people

# PT-141: more responders than placebo at 1.75 mg on all 7 measures

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

This paper set the bar for what counts as a real response to bremelanotide in women with low desire, found the 1.75 mg dose cleared it more often than placebo, and supplied the response definitions later used in the RECONNECT phase 3 studies.

- **Kind:** Randomized trial
- **Studied in:** People
- **Published:** 2019
- **Journal:** J Sex Med

## What they tested

The team wanted to set the smallest change in sexual function scores that patients would find meaningful, then use that cutoff to see how many women responded to bremelanotide (PT-141) versus placebo.

## How the study was done

A randomized, placebo-controlled, dose-finding phase 2b trial in premenopausal women with hypoactive sexual desire disorder (HSDD, low sexual desire), with or without female sexual arousal disorder (FSAD). Seven questionnaire-based endpoints were checked with up to 4 kinds of responder analysis, some planned and some post hoc (decided after the data came in).

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Cutoffs for a meaningful change, worked out from the trial's own data, lined up with the cutoffs clinical experts had estimated. On all 7 endpoints, the 1.75 mg arm had a statistically significant higher share of responders than placebo in the main analysis group. The team reported bremelanotide was safe and well tolerated in this trial.

## What it doesn’t show

Only premenopausal women diagnosed with HSDD and/or FSAD were studied, so the results may not apply to other people. The meaningful-change cutoffs came from the same trial they were used to judge, and some of the analyses were post hoc.

## The paper

Althof et al. Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide. J Sex Med. 2019.

- [PubMed (PMID 31277966)](https://pubmed.ncbi.nlm.nih.gov/31277966/)
- [The paper (DOI 10.1016/j.jsxm.2019.05.012)](https://doi.org/10.1016/j.jsxm.2019.05.012)

## The compound

- [PT-141: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

## With this study

### PT-141

- [PT-141: the full reference](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pt-141-10mg)

### Studies

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021)
- [PT-141: desire gains over placebo held across RECONNECT subgroups](https://pepvault.app/research/pt-141-reconnect-2022)
- [All 6 studies](https://pepvault.app/research#pt-141)

### Compared with

- [PT-141 vs Melanotan II](https://pepvault.app/peptides/compare/pt-141-vs-melanotan-ii)
- [PT-141 vs Oxytocin](https://pepvault.app/peptides/compare/pt-141-vs-oxytocin)
- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

## More studies on PT-141

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021) Meta-analysis · people · 2021
- [PT-141: desire gains over placebo held across RECONNECT subgroups](https://pepvault.app/research/pt-141-reconnect-2022) Randomized trial · people · 2022
- [PT-141 with alcohol was well tolerated in 24 healthy adults](https://pepvault.app/research/pt-141-clayton-2017) Randomized trial · people · 2017
- [PT-141: +0.7 vs +0.2 satisfying sexual events a month at 12 weeks](https://pepvault.app/research/pt-141-clayton-2016) Randomized trial · people · 2016
- [PT-141: nausea in 40.0% vs 1.3% on placebo in phase 3 safety data](https://pepvault.app/research/pt-141-clayton-2022) Systematic review · people · 2022
- [Every study on PT-141](https://pepvault.app/research#pt-141)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### PT-141

- [PT-141: the full reference](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pt-141-10mg)

### Studies

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021)
- [PT-141: desire gains over placebo held across RECONNECT subgroups](https://pepvault.app/research/pt-141-reconnect-2022)
- [All 6 studies](https://pepvault.app/research#pt-141)

### Compared with

- [PT-141 vs Melanotan II](https://pepvault.app/peptides/compare/pt-141-vs-melanotan-ii)
- [PT-141 vs Oxytocin](https://pepvault.app/peptides/compare/pt-141-vs-oxytocin)
- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

<!--promo-->

PepVault for iPhone

## Taking PT-141? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on PT-141](https://pepvault.app/research#pt-141)

## The library

- [PT-141](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
